? ȾɫÌåÏÔ´ø¼¼Êõ
? a.G´ø£¬GiemsaȾɫ¿ÉÏÔʾ³ö¸»º¬ AT¼î»ù¶ÔµÄDNA²¿·Ö ? b.Q´ø£¬Óà quinacrine mustardȾɫ£¬ ×ÏÍâµÆÏÂÏÔÉ« ? c. C´ø£¬ÏÔʾ³ö×ÅË¿Á£ÒìȾɫÖÊ
? d. R´ø£¬ÏÔʾ³ö¸»º¬GC¼î»ù¶ÔµÄDNA²¿·Ö¡£
»ÃµÆÆ¬4
µÚÒ»½Ú ȾɫÌå½á¹¹±äÒì Ò»¡¢½á¹¹±äÒì
¶þ¡¢½á¹¹±äÒìµÄ»úÀí
»ÃµÆÆ¬5
Ò»¡¢½á¹¹±äÒì £¨Ò»£©È±Ê§ £¨¶þ£©Öظ´ £¨Èý£©µ¹Î» £¨ËÄ£©Ò×λ
£¨Ò»£©È±Ê§(deletion or deficiency))
ȾɫÌåÄ³Ò»Çø¶Î£¬Á¬Í¬ËüËù´øÓеĻùÒòһͬ¶ªÊ§£¬´Ó¶øÒýÆð±äÒìµÄÏÖÏó¡£ Öмäȱʧ£¨interstitial deletion) Ä©¶Ëȱʧ£¨terminal deletion)
¶¥¶Ëȱʧ£ºÈ±Ê§µÄÇø¶ÎΪij±ÛµÄÍâ¶Ë ijһÕû±ÛȱʧÁ˾ͳÉΪ¶¥¶Ë×ÅË¿µãȾɫÌå Öмäȱʧ£ºÈ±Ê§µÄÇø¶ÎΪij±ÛµÄÄÚ¶Î
? ¶¥¶ËȱʧȾɫÌåºÜÄѶ¨ÐÍ£¬Òò¶ø½ÏÉÙ¼û
? £¨1£©¶ÏÍ·ºÜÄÑÓúºÏ£¬¶ÏÍ·¿ÉÄÜͬÁíÒ»ÓÐ×ÅË¿Á£µÄȾɫÌåµÄ¶ÏÍ·ÖØ½Ó£¬³ÉΪ˫×ÅÁ£È¾Ìå ? £¨2£©¶¥¶ËȱʧȾɫÌåµÄÁ½¸öæ¢ÃÃȾɫµ¥Ìå¿ÉÄÜÔÚ¶ÏÍ·Éϱ˴˽Ӻϣ¬ÐγÉË«×ÅË¿Á£È¾É«
Ìå
? Ë«×ÅË¿Á£È¾É«Ìå¾Í»áÔÚϸ°û·ÖÁѵĺóÆÚÊÜÁ½¸ö×ÅË¿Á£ÏòÏà·´Á½¼«Òƶ¯Ëù²úÉúµÄÀÁ¦Ëù
ÕÛ¶Ï£¬ÔÙ´ÎÔì³É½á¹¹µÄ±äÒì¶ø²»ÄÜÎȶ¨
? ÖмäȱʧȾɫÌåûÓжÏÍ·Íâ¶£¬±È½ÏÎȶ¨£¬Òò¶ø³£¼ûµÄȱʧȾɫÌå¶àÊÇÖмäȱʧµÄ £¨1£©È±Ê§ÔÓºÏÌ壺ij¸öÌåµÄÌåϸ°ûÄÚÔÓºÏÓÐÕý³£È¾É«Ìå¼°ÆäȱʧȾɫÌå ? £¨2£©È±Ê§´¿ºÏÌ壺ij¸öÌåµÄȱʧȾɫÌåÊÇ³É¶ÔµÄ Ï¸°ûÑ§ÌØÕ÷:
ȱʧ»·£¨deletion loop) ÖÐÆÚÓë¼äÆÚÔλÔÓ½»
ȾɫÌåÏÔ´ø¼¼Êõ
? ȱʧµÄÒÅ´«Ð§Ó¦
(1)ȾɫÌåµÄÄ³Ò»Çø¶ÎȱʧÁË£¬ÆäÉÏÔÀ´ËùÔØ»ùÒò×ÔÈ»¾Í¶ªÊ§ÁË£¬ÕâÊÇÓк¦ÓÚÉúÎïÉú³¤ºÍ·¢ÓýµÄ
º¬È±Ê§È¾É«ÌåµÄÅä×ÓÌåÒ»°ãÊǰÜÓýµÄ£¬»¨·ÛÓÈÆäÈç´Ë£¬ÅßÄÒµÄÄÍÐԱȻ¨·ÛÂÔÇ¿
? º¬È±Ê§È¾É«ÌåµÄ»¨·Û¼´Ê¹²»Ôø°ÜÓý£¬ÔÚÊÚ·ÛºÍÊܾ«¹ý³ÌÖУ¬Ò²¾ºÕù²»¹ýÕý³£µÄÐÛÅä×Ó£¬
Òò´Ë£¬È±Ê§È¾É«ÌåÖ÷ÒªÊÇͨ¹ý´ÆÅä×Ó¶øÒÅ´« »ÃµÆÆ¬12
(2)Èç¹ûȱʧµÄƬ¶Ï½ÏС£¬¿ÉÄÜ»áÔì³É ¼ÙÏÔÐÔµÄÏÖÏó McClintock(1931):
ÓñÃ×Ö²ÖêÑÕÉ«×ÏÉ«¡¢ÂÌÉ«(pl)£¬ λÓÚ6#³¤±ÛÍâ¶Î
XÉäÏß
plpl PlPl ×ÏÖê732Öê ÂÌÖê2Öê
£¨Ï¸°ûѧ¼ø¶¨¸ÃÇø¶ÎȱʧÁË£©
´íÎó£¡Î´ÕÒµ½ÒýÓÃÔ´¡£ ? Deletion mapping£º
ÈËÀàµÄȱʧÒÅ´«²¡£º è½Ð×ÛºÏÖ¢£¨cat cry syndrome):5p15.2
×îÃ÷ÏÔµÄÌØÕ÷ÊÇ»¼¶ù¿ÞÉùÇᣬÒôµ÷¸ß£¬³£·¢³ößäßäÉù¡£Í¨³£ÔÚÓ¤¶ùÆÚºÍÓ×¶ùÆÚزÕÛ¡£ ? ÂýÐÔ¹ÇËèÐÔ°×Ѫ²¡£¨chronic myelocytic leukemia,CML)
¹ûӬȱ¿Ì±íÐÍNotch phenotypeÊÇÒòΪ°üÀ¨ Notch »ùÒòÔÚÄÚµÄȾɫÌ寬¶Î·¢ÉúȱʧÔì³ÉµÄ ÉÏͼΪÕý³£±íÐÍ ÏÂͼΪͻ±äÐÍ »ÃµÆÆ¬21
ÖØ¸´(duplication or repeat ):ȾɫÌåÉÏÔö¼ÓÁËÏàͬµÄÄ³Ò»Çø¶Î£¬´Ó¶øÒýÆð±äÒìµÄÏÖÏó¡£ ´®ÁªÖظ´£¨tandem duplication)ÖØ¸´Æ¬¶Î½ô½ÓÔÚ¹ÌÓÐÆ¬¶ÎÖ®ºó£¬Á½ÕߵĻùÒò˳ÐòÒ»Ö¡£ ·´Ïò´®ÁªÖظ´£¨reverse duplication)ÖØ¸´Æ¬¶Î½ô½ÓÔÚ¹ÌÓÐÆ¬¶ÎÖ®ºó£¬µ«Öظ´Æ¬¶ÎÖеĻùÒò˳ÐòÏà·´¡£
? ÖØ¸´Çø¶ÎÄÚ²»ÄÜÓÐ×ÅË¿Á£,·ñÔòÖØ¸´È¾É«Ìå¾Í±ä³ÉË«×ÅË¿Á£µÄȾɫÌ壬¾Í»á¼ÌÐø·¢Éú½á
¹¹±äÒ죬ºÜÄÑÎȶ¨³ÉÐÍ¡£ ? ÖØ¸´ºÍȱʧ×ÜÊǰéËæ³öÏֵġ£Ä³È¾É«ÌåµÄÒ»¸öÇø¶Î×ªÒÆ¸øÍ¬Ô´µÄÁíÒ»¸öȾɫÌåÖ®ºó£¬Ëü
×Ô¼º¾Í³ÉΪȱʧȾɫÌåÁË¡£
ÖØÒÅ´«Ñ§Ð§Ó¦£º ¼ÁÁ¿Ð§Ó¦£º λÖÃЧӦ£º
¶¯Ì¬Í»±ä£¨dynamic mutation£©
DNAÐòÁÐÖÐÓÉÓڹѺËÜÕË´±´ÊýÄ¿µÄ±ä»¯£¬ÒýÆðÉúÎï±íÐ͸ıäµÄÍ»±ä£¬³ÆÎª¶¯Ì¬Í»±ä¡£¶¯Ì¬Í»±äͨ³£ÊÇÓÉÈýÁªÌåÃÜÂë×ÓÖØ¸´ÊýÄ¿µÄÔö¼Ó¶øÐγɵġ£
X´àÐÔȾɫÌå×ÛºÏÖ¢ÊÇÓÉÓÚÔÚXȾɫÌåP27.3λÖÃÉÏCGG¿½±´ÊýÄ¿Ôö¼Óµ½200ÒÔÉÏ£¬ÒýÆð»ùÒòµÄ¸Ä±ä£¬Ðγɺۼ£ºÜÖØµÄȾɫÌ壬ͻ±äµÄ²¿·ÖºÜÈÝÒ×±»´ò¶Ï£¬ËùÒÔ±»³ÆÎªÊÇ´àÐÔȾɫÌå¡£ »ÃµÆÆ¬28
´àÐÔλµãÊÇȾɫÌåÉÏÔÚÌØÊâÌõ¼þÏÂÒ×¶ÏÁѵÄλµã£¬¿ÉÄÜΪÊÕËõ»ò·ì϶¡£ÔÚÈËÀàȾɫÌåÉÏÒÑ
·¢ÏÖһϵÁеĴàÐÔλµã¡£ÆäÖÐÑо¿×îÏ꾡µÄλÓÚ X ȾɫÌåÉÏ£¬Ä¿Ç°·¢ÏÖÆäÓëÖÇÕÏÓйء£´àÐÔX×ÛºÏ֢ΪXÁ¬ËøÒÅ´«£¬³öÏÖ¼¸ÂÊÔÚÄÐÓ¤ÖÐΪ
1/2500£¬Ö÷Òª³ÉÒò¿ÉÄÜÊÇÒòΪCGGÈýºËÜÕÆ¬¶ÎÖØ¸´ÊýÄ¿µÄ±ä»¯¡£
»ÃµÆÆ¬29
ÈýÁªÌåÃÜÂë×ÓµÄÖØ¸´Óë¼²²¡
¼² ²¡ ÃÜÂë×Ó Õý³£¿½±´ »¼Õß¿½±´
¼¹Ë輡ÈâήËõÖ¢ CAG(gln) 11-33 40--62
ºàÍ¢¶ÙÖ¢ CAG(gln) 11-34 42--100 X´àÐÔȾɫÌå CGG(arg) 6-54 250-4000 ǿֱÐͼ¡ÓªÑø²»Á¼ CTG(leu) 7-23 49-75
СÄÔ¹²¼Ãʧµ÷ CAG(glu) 4-18 40-200

